---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-185076"
form_type: "8-K"
ticker: null
cik: "0001466301"
company_name: "Clovis Oncology, Inc."
filed_at: "2023-07-11T23:59:59+00:00"
generated_at: "2026-06-13T09:57:43.229887+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Clovis Oncology Chapter 11 plan effective; common stock canceled, no equity recovery expected

## Summary
- Effective July 10, 2023, Third Amended Joint Chapter 11 Plan of Liquidation became effective.
- All outstanding common stock canceled; no payment or distribution to equity holders anticipated.
- Directors and officers discharged and terminated as of the Effective Date.
- Company intends to file Form 15 to deregister securities and suspend SEC reporting.
- Liquidation Trustee appointed; contingent value rights possible only if creditors paid in full (>$250k).

## SEC filing metadata
- accession: 0001193125-23-185076
- form_type: 8-K
- cik: 0001466301
- company_name: Clovis Oncology, Inc.
- filed_at: 2023-07-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 3.03, 5.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1466301/000119312523185076/0001193125-23-185076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1466301/000119312523185076/d514612d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-185076
- JSON: https://secwatch.observer/filing/0001193125-23-185076.json
- Plain text: https://secwatch.observer/filing/0001193125-23-185076.txt

## Key facts
- Distress & Bankruptcy
  Clovis Oncology, Inc. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2022-12-11).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2022-12-11
  source text: On December 11, 2022, Clovis Oncology, Inc. (the “ Company ”) and certain of its subsidiaries, Clovis Oncology Ireland Limited and Clovis Oncology UK Limited (together with the Company, the “ Debtors ”), filed voluntary petitions under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (such court, the “ Court ” and such cases, the “ Cases ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1466301/000119312523185076/0001193125-23-185076-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.